MacroGenics reported $-0.58 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.





Eps Change Date
AbbVie USD 3.65 1 Jun/2026
Amgen USD 6.29 1.14 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
Biogen USD 3.6 0.03 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Genmab DKK 3.69 2.77 Dec/2025
Geron USD -0.02 0.01 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -0.13 1.15 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Xencor USD -0.29 1.42 Jun/2026